# AbbVie Inc. (ABBV) — Q1-2014 Earnings Results

**Report date:** 2014-04-25 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2014

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 0.36%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.71 | N/A | +3.95% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and ongoing investments. They acknowledged market challenges but remain focused on future growth.

**Key quotes:**

> Management highlighted the strong performance of key products.

> They emphasized ongoing investment in research and development.

> The team remains focused on long-term growth despite current challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock reacted negatively, declining by 0.36%. This could suggest that investors were looking for more comprehensive revenue details or guidance, which were not provided.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2014_